COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 14th April 2020. As a result, our offices will now be closed till 14th April 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804

Article view: 435

Article download: 224

Indian Journal of Clinical Anaesthesia


Hip replacement in a patient of sickle cell disease: an anaesthetic challenge


Full Text PDF Share on Facebook Share on Twitter


Author Details : Nitin Choudhary, Abhijit Kumar, Sonia Wadhawan, Poonam Bhadoria, Amit Kohli

Volume : 4, Issue : 4, Year : 2017

Article Page : 539-541


Suggest article by email

Abstract

Majority of surgical procedures in patients with sickle cell disease are a result of the disease process itself and require intervention for either treatment or prevention of certain complications. Avascular necrosis of femoral head is a known complication of sickle cell disease. Hereby we describe the successful anaesthetic management of a 45 year old male patient with sickle cell disease with avascular necrosis of femoral head who underwent total hip replacement surgery under central neuraxial blockade. Proper understanding of the disease process and its anaesthetic implications are essential for successful perioperative management of sickle cell disease patient.

Keywords: Avascular necrosis of femoral head, Sickle cell disease, Central neuraxial blockade

How to cite : Choudhary N, Kumar A, Wadhawan S, Bhadoria P, Kohli A, Hip replacement in a patient of sickle cell disease: an anaesthetic challenge. Indian J Clin Anaesth 2017;4(4):539-541

Copyright © 2017 by author(s) and Indian J Clin Anaesth. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (creativecommons.org)